JUN and neoplasm: When p-c-Jun expression level was examined in relation to ERβ2/cx status, p-c-jun IHC-score was significantly lower in ERβ2/cx-negative tumours (median p-c-Jun=5) compared to high ERβ2/cx expressors (median p-c-Jun=40; P<0.0001, Mann–Whitney rank sum test).